These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16485913)

  • 1. Pharmacokinetic interaction between levofloxacin and ciclosporin or tacrolimus in kidney transplant recipients: ciclosporin, tacrolimus and levofloxacin in renal transplantation.
    Federico S; Carrano R; Capone D; Gentile A; Palmiero G; Basile V
    Clin Pharmacokinet; 2006; 45(2):169-75. PubMed ID: 16485913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronopharmacokinetics of ciclosporin and tacrolimus.
    Baraldo M; Furlanut M
    Clin Pharmacokinet; 2006; 45(8):775-88. PubMed ID: 16884317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study.
    Margreiter R;
    Lancet; 2002 Mar; 359(9308):741-6. PubMed ID: 11888584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moxifloxacin does not alter ciclosporin pharmacokinetics in transplant patients: a multiple-dose, uncontrolled, single-centre study.
    Stass H; Delesen H; Kubitza D; Mai I; Bauer S; Roots I
    Clin Drug Investig; 2010; 30(5):279-87. PubMed ID: 20384384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients.
    Gustavsen MT; Midtvedt K; Robertsen I; Woillard JB; Debord J; Klaasen RA; Vethe NT; Bergan S; Åsberg A
    Clin Transl Sci; 2020 Nov; 13(6):1327-1335. PubMed ID: 32652886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients.
    Jones TE; Morris RG
    Clin Pharmacokinet; 2002; 41(5):381-8. PubMed ID: 12036394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of pharmacokinetic interference of moxifloxacin on cyclosporine and tacrolimus in kidney transplant recipients.
    Capone D; Tarantino G; Polichetti G; Kadilli I; Sabbatini M; Basile V; Carrano R; Nappi R; Federico S
    J Clin Pharmacol; 2010 May; 50(5):576-80. PubMed ID: 20089827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in elderly transplant recipients: a guide to clinically significant drug interactions.
    Kuypers DR
    Drugs Aging; 2009; 26(9):715-37. PubMed ID: 19728747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
    Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
    Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: randomised European multicentre trial.
    Kelly D; Jara P; Rodeck B; Lykavieris P; Burdelski M; Becker M; Gridelli B; Boillot O; Manzanares J; Reding R
    Lancet; 2004 Sep 18-24; 364(9439):1054-61. PubMed ID: 15380964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus and ciclosporin microemulsion in renal transplantation.
    Emovon OE; Browne BJ
    Lancet; 2002 Sep; 360(9335):799; author reply 800-1. PubMed ID: 12241844
    [No Abstract]   [Full Text] [Related]  

  • 15. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
    Lam H; Jeffery J; Sitar DS; Aoki FY
    Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients.
    Renton KW; Crocker JF; McLellan H; Acott PD
    Eur J Clin Pharmacol; 2004 Aug; 60(6):421-6. PubMed ID: 15232662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus and ciclosporin microemulsion in renal transplantation.
    Schieppati A; Perico N; Remuzzi G
    Lancet; 2002 Sep; 360(9335):799-800, author reply 800-1. PubMed ID: 12241845
    [No Abstract]   [Full Text] [Related]  

  • 18. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of limited sampling strategies for the estimation of mycophenolic acid area under the curve in adult kidney and liver transplant recipients receiving concomitant enteric-coated mycophenolate sodium and tacrolimus.
    Pawinski T; Luszczynska P; Durlik M; Majchrzak J; Baczkowska T; Chrzanowska M; Sobiak J; Glyda M; Kuriata-Kordek M; Kamińska D; Krajewska M; Klinger M
    Ther Drug Monit; 2013 Dec; 35(6):760-9. PubMed ID: 24192641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.
    Webster AC; Woodroffe RC; Taylor RS; Chapman JR; Craig JC
    BMJ; 2005 Oct; 331(7520):810. PubMed ID: 16157605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.